Inhibikase Therapeutics Inc (IKT)

Financing Cash Flow

$111.31M

TTM · Period ending: · USD

IKT logo

IKT Financing Cash Flow

Latest reported$111.31M
IKT TTM Cash from Financing (-$22.81K → $111.31M)
High-resolution chart · PNG

IKT financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibikase Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
111,314,314
111,360,574
108,462,963
99,582,100
99,898,184
103,110,669
103,477,668
3,655,105
3,473,221
192,979
8,405,003
8,543,107
8,543,037
8,579,023
-204,769
-204,769
-174,877
41,298,564
41,093,671
55,977,544
55,880,520
14,412,388
15,072,170
188,297
255,429
250,120
-22,810
-38,249
-48,294
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.